Honoring Employee Giving and Volunteerism
This giving season, we’re proud to highlight the incredible generosity of our employees who dedicate their time, talents, and financial resources to support and strengthen the communities where we live…
This giving season, we’re proud to highlight the incredible generosity of our employees who dedicate their time, talents, and financial resources to support and strengthen the communities where we live…
UnitedHealth Group (NYSE: UNH) has announced its financial guidance in advance of its annual Investor Conference, which will take place on December 4, starting at 8:00 a.m. ET. The company…
The American Red Cross’s Cell and Gene Therapy Solutions (CGTS) division, a leading provider of allogeneic cell therapy materials, has selected Accellix, Inc. to supply its automated flow cytometry platform…
Janux Therapeutics, Inc. (Nasdaq: JANX), a clinical-stage biopharmaceutical company developing innovative immunotherapies, announced positive interim clinical data for its JANX007 program in metastatic castration-resistant prostate cancer (mCRPC). The company will…
Bayer continues to enhance its comprehensive radiology portfolio by advancing innovations in Artificial Intelligence (AI) and expanding its product pipeline. These advancements will be showcased at the 2024 Radiological Society…
Sickday Medical House Calls, the largest and longest-serving medical house call practice in New York City, is reshaping the way travelers experience healthcare. For nearly two decades, Sickday has been…
Teladoc Health has introduced a groundbreaking technology that combines artificial intelligence (AI) and real-time monitoring to enhance patient safety in hospitals. This innovative solution, known as Virtual Sitter, is designed…
Galderma recently announced that the full results from the Phase III OLYMPIA 1 trial, which evaluated the efficacy and safety of nemolizumab in adults with moderate-to-severe prurigo nodularis, were published…
Oxford Nanopore Technologies, a leader in advanced nanopore-based molecular sensing technology, has announced a groundbreaking collaboration with UK Biobank to create the world’s first large-scale, comprehensive epigenetic dataset. Utilizing Oxford…
The Menarini Group, a global leader in pharmaceuticals and diagnostics, along with its subsidiary Stemline Therapeutics, will present new and expanded data on ORSERDU® (elacestrant) at the 2024 San Antonio…
HCA Healthcare, Inc. (NYSE:HCA), one of the largest healthcare providers in the United States, proudly announced the success of its sixth annual “Crush the Crisis” national prescription drug take-back day,…
The BioFuture™ 2024 conference, organized by Demy-Colton, concluded in New York and virtually, marking the largest turnout in the event’s history. This year’s conference brought together more than 100 speakers,…